Collection

VPAG quarterly net sales and payment information

Information on how the voluntary scheme for branded medicines pricing, access and growth (VPAG) is controlling spend on branded medicines in the NHS.

• From: Department of Health and Social Care
• Published: 31 July 2024
• Last updated: 21 March 2025 — See all updates

This page holds quarterly aggregate net sales from:

• 2024 voluntary scheme for branded medicines pricing, access and growth members
• companies regulated by the Branded Health Service Medicines (Costs) Regulations 2018

It also holds information received on parallel imports.

The voluntary scheme for branded medicines pricing, access and growth (VPAG) started on 1 January 2024, replacing the voluntary scheme for branded medicines pricing and access (VPAS).

2025

• Voluntary scheme aggregate net sales and payment information: February 2025
  • 21 March 2025
  • Transparency data

2024

• Voluntary scheme aggregate net sales and payment information: November 2024
  • 13 March 2025
  • Transparency data
• Voluntary scheme aggregate net sales and payment information: September 2024
  • 21 October 2024
  • Transparency data
• Voluntary scheme aggregate net sales and payment information: May 2024
  • 31 July 2024
  • Transparency data

Published 31 July 2024

Last updated 21 March 2025 + show all updates

1. 21 March 2025

   Added 'Voluntary scheme aggregate net sales and payment information: February 2025' to the collection.

2. 16 December 2024

   Added 'Voluntary scheme aggregate net sales and payment information: November 2024' to the collection.

3. 21 October 2024

   Added 'Voluntary scheme aggregate net sales and payment information: September 2024' to the collection.

4. 31 July 2024

   First published.